Superior Science.
Unmatched Products.
-
Science-Backed Softgel Formulation
Loaded with 25mg Cannabidiol (CBD) and 10mg Beta-
Caryophyllene (BCP) from broad spectrum hemp extract. -
Clinically Proven Efficacy
Powered by the VESIsorb® delivery system for
dramatically improved bioavailability and absorption. -
Seed to Solution Traceability
100% USA grown hemp that exceeds all FDA compliance
standards, in accordance with the 2018 Farm Bill.
Millions of consumers around
the world are turning to hemp
derived cannabinoids for:
Pain
Uses identified include: aches, discomfort, joint pain,
muscle soreness, muscle recovery, and post-op treatment.
Mental Health
Uses identified include: stress, anxiety, addictions,
overall mood, and relaxation.
Sleep
Uses identified include: insomnia, relaxation, time it
takes to fall asleep, and wake up feeling well rested.
In 2017, The National Academy of Sciences, Engineering, and Medicine reviewed Cannabis and cannabinoids from the perspective of human health.1)
Over 10,000 cannabinoids and cannabis focused medical studies.
Found conclusive evidence of cannabinoids as effective in treating chronic pain in adults and for use as antiemetics.
In 2018, WHO published its comprehensive opinion on CBD, stating the ingredient has low toxicity with no known adverse effects in human studies.2)
No dependence potential reported. No abuse potential reported.
No significant psychoactive effects.
“a limited number of preclinical studies which suggest that CBD may have therapeutic properties on opioid, cocaine, and psychostimulant addiction…”
01 Cultivation
- 100% U.S. sun grown hemp from GAP certified farm partners.
- Tested for soil type, nutrient levels, heavy metals, and pesticides.
- All plants are hand-harvested and bucked in compliance with Good Harvesting and Agricultural Practices.
02 Remediation
- Proprietary extraction methods to achieve high CBD concentrations with no THC.
- Rigorously tested to confirm unmatched safety results, as proven in various toxicology and stability studies.
- Pioneering innovation for future Promise Nutraceutical products.
03 Production
- NSF/GMP certified production and packaging facility.
- Triple lab tested to ensure product safety and performance parameters meet those from peer-reviewed published studies.
- Unparalleled production capacity.
Overcoming Formulation Obstacles |
Industry Obstacle
It is clear in the scientific community that cannabinoids are
very poorly absorbed in the human body, often leading up
to 95% of these ingredients wasted after consumption due
to their lipophilicity and extensive first pass metabolism.
Promise Nutraceuticals Solution
To overcome these limitations, Promise has leveraged the VESIsorb®
technology platform to mitigate the extensive first pass metabolism
of cannabinoids while setting new industry benchmarks for
pharmacokinetic product performance (Cmax, AUC, Tmax).
The Key To Unlocking Unlimited Potential
Unmatched Performance
Knaub et al., Molecules 24, 2967, 2019
Peer-Reviewed & Published Study
In a double-blind, cross-over study, the Promise
Nutraceutical CBD VESIsorb® formulation showed
statistically significant improvements for all measured
pharmacokinetic parameters, including maximal plasma
CBD concentration (Cmax), area under the curve (AUC),
and time to peak absorption (Tmax).
440%
Better Efficacy
300%
Faster Onset
